1122TiPPembrolizumab in patients with recurrent or metastatic cutaneous squamous cell carcinoma (cSCC): The phase II KEYNOTE-629 study. (23rd October 2018) - Licitra, L F; Siu, L L; Cohen, E E W; Zhang, P; Gumuscu, B; Swaby, R; Harrington, K